Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials
July 05, 2022 16:01 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,...
Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions
June 28, 2022 11:00 ET
|
Norstella
Yardley, PA, June 28, 2022 (GLOBE NEWSWIRE) -- Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma...
World Clinical Trials Market Report 2022: A Decline of 6% in 2020 Due to COVID-19 but a Market Valued at $78.3 Billion by 2030
June 28, 2022 04:28 ET
|
Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by Indication (Pain...
Curium Announces the Submission of its Marketing Authorization Application for [18F]-DCFPyL to the European Medicines Agency
June 27, 2022 01:00 ET
|
Curium
Submission follows the completion of Phase III PYTHON clinical trial of [18F]-DCFPyL for recurrent prostate cancer in Europe in May 2022Phase III PYTHON clinical trial results to be presented at the...
Cognition Therapeutics Doses First Patient with Dementia with Lewy Bodies in Phase 2 Clinical Study of CT1812
June 23, 2022 07:30 ET
|
Cognition Therapeutics, Inc.
- Study Supported by $30M NIA Grant Award and Conducted in Collaboration with University of Miami Miller School of Medicine and the Lewy Body Dementia Association - NEW YORK, June 23, 2022 (GLOBE...
Global Clinical Trials Connect Conference 2022: An Invaluable Networking Opportunities with Decision Makers and focus on real Case Studies - September 21-22, 2022
June 23, 2022 03:38 ET
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Connect 2022" conference has been added to ResearchAndMarkets.com's offering. The Global Clinical Trials Connect 2022 will...
POINT Biopharma announces appointment of Chris Horvath as EVP, Commercial
June 21, 2022 08:30 ET
|
POINT Biopharma
Mr. Horvath will lead the commercialization of POINT’s pipeline. He brings over a decade of experience in pharmaceutical commercialization, most recently as the VP and Head of Prostate Cancer...
Global CFTR Modulators Market Report 2022-2028: Clinical Insight On Over 30 CFTR Modulators In Trials
June 21, 2022 04:48 ET
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Axiom Exhibiting and Presenting “Saving People’s Lives – The Value of Time” at DIA Global Annual Meeting 2022
June 20, 2022 10:09 ET
|
Axiom Real-Time Metrics Inc
TORONTO, June 20, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Parexel Expands Patient Access to Clinical Trials Through New Community Alliance Network
June 16, 2022 09:09 ET
|
Parexel International LLC
BOSTON, and Durham, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the launch of its Community Alliance Network, a novel...